Unmet needs in radiation therapy for liver cancer

Laura A. Dawson, MD, FASTRO, Princess Margaret Cancer Center, Toronto, Canada, discusses the gaps in radiotherapy research for hepatocellular carcinoma (HCC). There is potential for radiotherapy to improve clinical outcomes and quality of life across the spectrum of HCC disease, from early-stage disease to palliative care. This interview took place at the American Society for Radiation Oncology (ASTRO) 2022 Congress in San Antonio, Tx.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.